Relmada Therapeutics annual revenue
2012
2013
2022
2023
2024
2025
Relmada Therapeutics Revenue Growth & History (RLMD)
Relmada Therapeutics reported $0 in revenue for fiscal 2025.
View full Relmada Therapeutics company overviewRelmada Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
| 2013 · Aug 31 | 2013-08-31 | $5,129 | −$2,812 | −35.41% |
| 2012 · Aug 31 | 2012-08-31 | $7,941 | — | — |
Relmada Therapeutics quarterly revenue
Q2.12
Q3.12
Q1.13
Q1.13
Q2.13
Q4.13
Q1.14
Q1.14
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2014 · Feb 28 | 2014-02-28 | $682 | −$1,664 | −70.93% |
| Q1 2014 · Nov 30 | 2013-11-30 | $1,850 | −$299 | −13.91% |
| Q4 2013 | 2013-08-31 | $0 | — | — |
| Q2 2013 | 2013-05-31 | $634 | $234 | +58.50% |
| Q1 2013 · Feb 28 | 2013-02-28 | $2,346 | −$3,680 | −61.07% |
| Q1 2013 · Nov 30 | 2012-11-30 | $2,149 | — | — |
| Q3 2012 | 2012-05-31 | $400 | — | — |
| Q2 2012 | 2012-02-29 | $6,026 | — | — |
Relmada Therapeutics revenue growth trends
Relmada Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Relmada Therapeutics source filings ↗